𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Motexafin Gadolinium for the Treatment of Metastatic Renal Cell Carcinoma: Phase II Study Results

✍ Scribed by Robert J. Amato; Jaroslaw Jac; Joan Hernandez-McClain

Book ID
119935414
Publisher
CIG Media Group, LP.
Year
2008
Tongue
English
Weight
122 KB
Volume
6
Category
Article
ISSN
1558-7673

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of constant-infusion fl
A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma
✍ Mary J. Wilkinson; John W. Frye; Eric J. Small; Alan P. Venook; Peter R. Carroll πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 347 KB πŸ‘ 2 views

Background. Twenty-nine patients with metastatic renal cell carcinoma (RCC) were treated with constantinfusion floxuridine (FUdR, Roche Laboratories, Nut-Methods. The initial dosage was 0.075 mg/kg/day for 14 days every 28 days and was increased or decreased by 0.025-mg/kg/day increments at each sub